Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Randomized phase II trial to compare the effectiveness of two different regimens of
Ro 31-7453 in treating patients who have recurrent or refractory metastatic colorectal
cancer.